Steward Partners Investment Advisory
PRME icon

Steward Partners Investment Advisory’s Prime Medicine PRME Stock Holding History

Steward Partners Investment Advisory’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$400K Sell
108,290
-9,166
-8% -$30.4K ﹤0.01% 1835
2026
Q1 		$409K Sell
117,456
-950
-0.8% -$3.62K ﹤0.01% 1618
2025
Q4 		$411K Sell
118,406
-7,981
-6% -$35.5K ﹤0.01% 1534
2025
Q3 		$700K Buy
+126,387
New +$513K ﹤0.01% 1212

Other funds holding PRME

Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Steward Partners Investment Advisory's PRME Position: Q2 2026 in Review

Steward Partners Investment Advisory reduced its Prime Medicine (PRME) stake by 7.8% in Q2 2026, selling an estimated $30.4K and leaving 108,290 shares worth $400K. The position accounts for ﹤0.01% of the portfolio, ranked #1835.

Steward Partners Investment Advisory first reported a position in PRME in Q3 2025 and has held it in 4 quarters since. The position peaked at $700K in Q3 2025. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Steward Partners Investment Advisory held 108,290 shares of Prime Medicine worth $400K as of Q2 2026.
  • Steward Partners Investment Advisory sold 9,166 Prime Medicine shares in Q2 2026, an estimated $30.4K.
  • Prime Medicine made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #1835 holding.
  • Steward Partners Investment Advisory first reported a position in Prime Medicine in Q3 2025 and has held it in 4 quarters since.
  • Steward Partners Investment Advisory's Prime Medicine position peaked at $700K in Q3 2025.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.